Literature DB >> 18524069

Constitutional law--substantive due process--en banc D.C. Circuit rejects fundamental right to experimental medications.--Abigail Alliance for Better Access to Developmental Drugs v. von Eschenbach, 495 F.3d 695 (D.C. Cir. 2007)(en banc), cert. denied, 128 S. Ct. 1069 (2008).

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18524069

Source DB:  PubMed          Journal:  Harv Law Rev        ISSN： 0017-811X


× No keyword cloud information.
  3 in total

1.  Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium study.

Authors:  Stacey L Berg; Naomi Winick; Ashish Mark Ingle; Peter C Adamson; Susan M Blaney
Journal:  Pediatr Blood Cancer       Date:  2010-07-15       Impact factor: 3.167

2.  Ethics of ongoing cancer care for patients making risky decisions.

Authors:  Jeffrey Peppercorn
Journal:  J Oncol Pract       Date:  2012-06-26       Impact factor: 3.840

3.  (R)evolution: toward a new paradigm of policy and patient advocacy for expanded access to experimental treatments.

Authors:  Melissa Hogan
Journal:  BMC Med       Date:  2016-02-29       Impact factor: 8.775
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.